This inventor holds 2 USPTO granted patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: Innovator Spotlight: Anna Maria Vandendriessche
Introduction: Anna Maria Vandendriessche, based in Oostmalle, Belgium, is a prominent inventor known for her contributions to pharmaceutical formulations. With two patents to her name, she has made significant strides in her field, particularly in the process of preparing enantiomerically pure compounds.
Latest Patents: Anna's latest innovations include a patented method for preparing (+)-6-(4-chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl!-1-methyl-1H-benzotriazole. This process involves the resolution of (±)-6-(4-chlorophenyl)-hydrazinomethyl)-1-methyl-1H-benzotriazole and the conversion of the enantiomerically pure hydrazine intermediate into the desired compound. These achievements underscore her expertise in synthetic chemistry.
Career Highlights: Anna Maria is currently employed at Janssen Pharmaceutica NV, a well-respected company in the pharmaceutical industry. Her work focuses on innovative solutions that aim to enhance the efficacy of drug development. Her dedication and technical skills have positioned her as a valuable contributor to her team and the broader scientific community.
Collaborations: Throughout her career, Anna has worked alongside other notable scientists, including her coworkers Albert Louis Willemsens and Walter Louis Verstappen. These collaborations have fostered an environment of innovative thinking and knowledge sharing, enabling her to achieve groundbreaking results.
Conclusion: Anna Maria Vandendriessche is a distinguished inventor whose work is making waves in pharmaceutical science. With her two patents and contributions in the domain of enantiomerically pure compounds, she exemplifies the spirit of innovation necessary for advancing medical therapies. Her journey serves as an inspiration for aspiring inventors in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
